Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV‐infected Individuals von Rotger, M, Tegude, H, Colombo, S, Cavassini, M, Furrer, H, Décosterd, L, Blievernicht, J, Saussele, T, Günthard, H F, Schwab, M, Eichelbaum, M, Telenti, A, Zanger, U M

Volltext

Selective Induction of Human Hepatic Cytochromes P450 2B6 and 3A4 by Metamizole von Saussele, T, Burk, O, Blievernicht, J K, Klein, K, Nussler, A, Nussler, N, Hengstler, J G, Eichelbaum, M, Schwab, M, Zanger, U M

Volltext

TNFα Mediated IL-6 Secretion Is Regulated by JAK/STAT Pathway but Not by MEK Phosphorylation and AKT Phosphorylation in U266 Multiple Myeloma Cells von Yoon, Sung-Soo, Ahn, Kwang-Sung, Jung, Woo June, Lee, Hyun Jung, Bae, Eun-Kyung, Choi, Jee-Hye, Park, Juwon, Oh, Jeong-In, Lee, Chansu, Lee, Dong Soon

Volltext

Doxorubicin Differentially Induces Apoptosis, Expression of Mitochondrial Apoptosis-Related Genes, and Mitochondrial Potential in BCR-ABL1-Expressing Cells Sensitive and Resistant... von Skorski, Tomasz, Pawlowska, Elzbieta, Bialkowska-Warzecha, Jolanta, Hoser, Grazyna, Synowiec, Ewelina, Blasiak, Janusz

Volltext

Asthma Management in Sickle Cell Disease von Gomez, Esteban, Morris, Claudia R.

Volltext

Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavire... von Klein, Kathrin, Lang, Thomas, Saussele, Tanja, Barbosa-Sicard, Eduardo, Schunck, Wolf-Hagen, Eichelbaum, Michel, Schwab, Matthias, Zanger, Ulrich M

Volltext

Recombinant Production of Human Microsomal Cytochrome P450 2D6 in the Methylotrophic Yeast Pichia pastoris von Dietrich, Matthias, Grundmann, Lisa, Kurr, Katja, Valinotto, Laura, Saussele, Tanja, Schmid, Rolf D, Lange, Stefan

Volltext

Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV von Proetel, Ulrike

Volltext bestellen

Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib von Hanfstein, Benjamin

Volltext bestellen

The concept of treatment-free remission in chronic myeloid leukemia von Saußele, S, Richter, J, Hochhaus, A, Mahon, F-X

Volltext

Chronic myeloid leukaemia von Cortes, Jorge, Pavlovsky, Carolina, Saußele, Susanne

Volltext

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia von Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., Hjorth-Hansen, H., Hughes, T. P., Janssen, J. J. W. M., Kantarjian, H. M., Kim, D. W., Larson, R. A., Lipton, J. H., Mahon, F. X., Mayer, J., Nicolini, F., Niederwieser, D., Pane, F., Radich, J. P., Rea, D., Richter, J., Rosti, G., Rousselot, P., Saglio, G., Saußele, S., Soverini, S., Steegmann, J. L., Turkina, A., Zaritskey, A., Hehlmann, R.

Volltext

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML) von Hanfstein, B, Müller, M C, Hehlmann, R, Erben, P, Lauseker, M, Fabarius, A, Schnittger, S, Haferlach, C, Göhring, G, Proetel, U, Kolb, H-J, Krause, S W, Hofmann, W-K, Schubert, J, Einsele, H, Dengler, J, Hänel, M, Falge, C, Kanz, L, Neubauer, A, Kneba, M, Stegelmann, F, Pfreundschuh, M, Waller, C F, Branford, S, Hughes, T P, Spiekermann, K, Baerlocher, G M, Pfirrmann, M, Hasford, J, Saußele, S, Hochhaus, A

Volltext

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV von Miranda, M B, Lauseker, M, Kraus, M-P, Proetel, U, Hanfstein, B, Fabarius, A, Baerlocher, G M, Heim, D, Hossfeld, D K, Kolb, H-J, Krause, S W, Nerl, C, Brümmendorf, T H, Verbeek, W, Fauser, A A, Prümmer, O, Neben, K, Hess, U, Mahlberg, R, Plöger, C, Flasshove, M, Rendenbach, B, Hofmann, W-K, Müller, M C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R, Saußele, S

Volltext

Survival with chronic myeloid leukaemia after failing milestones von Lauseker, Michael, Hehlmann, Rüdiger, Hochhaus, Andreas, Saußele, Susanne

Volltext

Management of chronic myeloid leukemia in blast crisis von Saußele, S., Silver, Richard T.

Volltext

Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Hochhaus, A., Saussele, S., Rosti, G., Mahon, F.-X., Janssen, J.J.W.M., Hjorth-Hansen, H., Richter, J., Buske, C.

Volltext

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV von Kalmanti, L, Saussele, S, Lauseker, M, Müller, M C, Dietz, C T, Heinrich, L, Hanfstein, B, Proetel, U, Fabarius, A, Krause, S W, Rinaldetti, S, Dengler, J, Falge, C, Oppliger-Leibundgut, E, Burchert, A, Neubauer, A, Kanz, L, Stegelmann, F, Pfreundschuh, M, Spiekermann, K, Scheid, C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R

Volltext

Evidence for local carbon‐cycle perturbations superimposed on the Toarcian carbon isotope excursion von Wang, Yunfeng, Ossa Ossa, Frantz, Wille, Martin, Schurr, Simon, Saussele, Mario‐Erich, Schmid‐Röhl, Annette, Schoenberg, Ronny

Volltext

A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs von Réa, Delphine, Mauro, Michael J., Boquimpani, Carla, Minami, Yosuke, Lomaia, Elza, Voloshin, Sergey, Turkina, Anna, Kim, Dong-Wook, Apperley, Jane F., Abdo, Andre, Fogliatto, Laura Maria, Kim, Dennis Dong Hwan, le Coutre, Philipp, Saussele, Susanne, Annunziata, Mario, Hughes, Timothy P., Chaudhri, Naeem, Sasaki, Koji, Chee, Lynette, García-Gutiérrez, Valentin, Cortes, Jorge E., Aimone, Paola, Allepuz, Alex, Quenet, Sara, Bédoucha, Véronique, Hochhaus, Andreas

Volltext